PE / Debt HealthTech / Life Sciences Investors in Canada

Focuses on emerging growth companies primarily in financial services, technology, and resource sectors, providing private equity, private debt, and venture capital.

Invests in small and medium-sized Canadian companies in the business and healthcare services and telecom industries.

North American private equity firm focused on selectively acquiring significant interests in high-quality businesses with meaningful growth potential, primarily in services sub-sectors.

BDC's debt financing arm providing loans to Canadian businesses across all stages. Over $9.7B in annual loan acceptances across 123+ business centres serving 60,000+ clients. Products include tech com

Leading Canadian mid-market private equity firm with 5 funds raised and 36 deals recorded.

BMO's technology and innovation banking group launched in 2019 providing venture debt and growth financing to Canadian tech companies. Expanded aggressively post-SVB to capture market share.

Canada's second-largest pension fund and one of the world's largest institutional investors. Active direct investor and LP in the Canadian VC ecosystem.

Strategic advice, cash management, and flexible capital solutions to innovation companies. Financing from $1M to $100M+.

Leading Canadian mid-market PE firm investing through buyouts, growth and acquisition financings since 2002.

Founder-friendly PE firm focusing on lower mid-market businesses with a focus on generational transitions and succession planning.

Connects Canadian businesses of all sizes and maturities, across all industries, to non-dilutive capital through debt financing against tax credits.

Investment management firm specializing in infrastructure and real estate, a subsidiary of Fengate Corporation operating since 1974.

Publicly listed provider of flexible growth and alternative capital, supporting revenue-generating, VC-backed, and founder-owned companies seeking growth capital with minimal dilution.

Largest non-bank venture debt lender globally with $10B+ portfolio. Active lender to Canadian tech and life sciences companies. Publicly traded (NYSE: HTGC). Provides venture debt from $5M-$200M+.

Non-bank venture lending company providing venture debt to VC-backed technology, life sciences, healthcare, and sustainability companies. Publicly traded (NASDAQ: HRZN). Active in the North American m

Toronto-based private equity fund manager focused on buyout opportunities in the Canadian and American mid-market.

JPMorgan's Canadian innovation economy unit expanding aggressively with 5 dedicated tech bankers. Hired Scotiabank's former head of TIB (David Rozin) to lead Canadian expansion, picking up hundreds of

National Bank's technology banking group offering venture lending, growth and M&A financing for tech companies for over 20 years. Acquired SVB's ~C$1B Canadian loan portfolio in 2023. Also operates NA

Making private equity investments since 1987 on behalf of OMERS, one of Canada's largest pension plans with over $60.8B in assets; manages over $6.5B globally.

Founded in 1984, one of Canada's oldest private equity firms committed to acquiring and building high-quality businesses in partnership with talented management teams.

Toronto-based middle-market private equity firm with 4 funds and 235 deals recorded, primarily in healthcare, financial, and business services.

Private equity fund exclusively focused on high-growth opportunities in the healthcare field.

Founded in 1994, Toronto-based private equity firm managing several portfolios with assets of $85M.

Backer of Canada's most daring innovators and idea generators; RBC's technology growth banking and venture arm.

Scotiabank's tech lending arm with ~C$2B lent to Canadian tech companies including BenchSci, Helcim, GeoComply, and Field Effect. Launched in 2019, expanded post-SVB collapse. Also operates via subsid

Venture banking division of Stifel providing venture debt ($1M-$50M+), treasury management, and capital raising for seed through IPO-stage tech companies. Over 100 bankers, $10B+ in loan commitments.

Non-bank venture debt and equipment financing provider for growth-stage companies backed by leading venture capital firms. Publicly traded (NASDAQ: TRIN). Active lender in the North American market in

Montreal-based PE firm partnering with management teams of mid-market businesses in Quebec and Canada to drive growth.

Venture capital and private equity manager of Golden Opportunities Fund Inc. and First Nations and Métis Fund (FNMF), with 7 funds and 179 deals.

Pioneered venture debt in 1980. $7.8B deployed across 1,400+ companies including Canadian firms. Now investing out of 11th institutional fund. Acquired by P10 in 2022. Flexible, founder-friendly lendi